Elite in Transcatheter Aortic Valve Replacement (TAVR)

Dr. Susheel K. Kodali

Interventional Cardiology | Cardiology
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Susheel Kodali is an Interventional Cardiologist and a Cardiologist in New York, New York. Dr. Kodali is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Aortic Valve Stenosis, Tricuspid Regurgitation, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 451 peer reviewed articles and participating in 20 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 264 articles in the study of Transcatheter Aortic Valve Replacement (TAVR).

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

20 Clinical Trials

Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: August 24, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
Clinical Study of Edwards Cardioband FIT Valve Repair System
Clinical Study of Edwards Cardioband FIT Valve Repair System
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation: (Millipede Feasibility Study)
A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation: (Millipede Feasibility Study)
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
Enrollment Status: Active_not_recruiting
Publish Date: March 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Enrollment Status: Completed
Publish Date: March 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
JENAVALVE ALIGN-AS TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)
JENAVALVE ALIGN-AS TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)
Enrollment Status: Unknown
Publish Date: November 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: November 18, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 19 Less Clinical Trials

451 Total Publications

DurAVR - a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI.
DurAVR - a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: September 17, 2025
Similar Doctors
Martin B. Leon
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. Martin B. Leon
Interventional Cardiology | Cardiology
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. Martin B. Leon
Interventional Cardiology | Cardiology
161 Fort Washington Ave, 
New York, NY 
 (0.1 miles away)
212-342-3616
Languages Spoken:
English
See accepted insurances

Martin Leon is an Interventional Cardiologist and a Cardiologist in New York, New York. Dr. Leon is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Aortic Valve Stenosis, Tricuspid Regurgitation, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. Annapoorna S. Kini
Interventional Cardiology | Cardiology
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. Annapoorna S. Kini
Interventional Cardiology | Cardiology

Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (3.5 miles away)
212-731-7822
Languages Spoken:
English
See accepted insurances

Annapoorna Kini is an Interventional Cardiologist and a Cardiologist in New York, New York. Dr. Kini is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). Her top areas of expertise are Coronary Heart Disease, Aortic Valve Stenosis, Heart Attack, Atherectomy, and Percutaneous Coronary Intervention (PCI).

George D. Dangas
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. George D. Dangas
Interventional Cardiology | Cardiology
Elite in Transcatheter Aortic Valve Replacement (TAVR)
Dr. George D. Dangas
Interventional Cardiology | Cardiology

Icahn School Of Medicine At Mount Sinai

2510 30th Ave, 
Astoria, NY 
 (5.1 miles away)
718-932-1000
Languages Spoken:
English
See accepted insurances

George Dangas is an Interventional Cardiologist and a Cardiologist in Astoria, New York. Dr. Dangas is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Coronary Heart Disease, Heart Attack, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kodali's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 12 Advanced Conditions
View All 40 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile